MTR-601

DRUG2 trials

Sponsors

Motric Bio

Conditions

Cerebral PalsyCervical DystoniaDystoniaHereditary Spastic ParaplegiaHypertonia, MuscleMultiple SclerosisMuscle SpasticitySpinal Cord Injuries

Phase 1

Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals

CompletedNCT06117020

Motric BioCerebral Palsy, Dystonia, Hereditary Spastic Paraplegia +5

Start: 2023-09-11End: 2024-10-16Updated: 2026-06-05

Phase 2

Study of the Oral Treatment MTR-601 in Cervical Dystonia

TerminatedNCT06830642

Motric BioCervical Dystonia

Start: 2025-02-28End: 2025-12-18Updated: 2026-09-17